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 INTRODUCTION
Autologous fat grafting is widely used in 
plastic surgery to restore contour, increase volume and 
improve irradiated skin in breast reconstructive surgery1-4. 
The risk of tumor recurrence is unknown when this 
type of reconstruction is performed simultaneously to 
conservative surgery, because there are no studies in 
the literature that use this method in the immediate 
breast reconstruction. Rigotti et al.5 described local 
and regional recurrence after radical mastectomy with 
fat graft reconstruction in 6.5% of 137 patients in 7.6 
years of follow-up. The author considered this incidence 
comparable to that observed in large randomized 
trials after mastectomy. Rietjens et al.6 evaluated 158 
patients who underwent 194 fat grafting procedures. He 
observed only one case of local recurrence, but probably 
already existed before fat grafting, since the diagnosis 
was made only two weeks after the procedure. The data 
were not considered relevant. Petit et al.7, on their turn, 
conducted a case-control study, in which 321 patients 
who underwent fat grafting for late breast reconstruction 
were compared with 642 women with similar cancer 
treatment, but without reconstruction. Invasive tumors 
accounted for 89% of the cases, 61% of the patients 
underwent mastectomy and the mean follow-up was 
56 months after primary surgery and 26 months after 
the fat grafting procedure. They diagnosed eight cases 
of local recurrence in the fat grafting group and 19 in 
the control group. There was no significant difference 
in patients with invasive carcinoma. In the group of 
patients with intraepithelial carcinoma who underwent 
fat grafting, local recurrence increased (p<0.001). Of 
the local recurrences in the group of intraepithelial 
carcinomas, three occurred after mastectomy and one 
after conservative surgery.
A systematic review by Claro et al.8 demonstrated 
that these three studies evaluated a total of 616 patients 
(mean follow-up of 45.17 months) with 14 cases of 
local recurrence (2.27%). In most recurrencecases, the 
initial treatment of breast cancer was mastectomy. They 
identified no significant differences in the cumulative 
1 - Clinics Hospital of Porto Alegre, Breast Unit, Porto Alegre, Rio Grande do Sul State, Brazil.
Original Article
A B S T R A C T
Objective: to evaluate local and systemic recurrence of breast cancer in patients submitted to autologous fat grafting in the immediate 
reconstruction after conservative surgery for breast cancer. Methods: this is a historical cohort study comparing 167 patients submitted 
to conservative surgery without reconstruction (conservative surgery group) with 27 patients submitted to conservative treatment with 
immediate graft reconstruction, following the Coleman’s technique (lipofilling group). All patients had invasive carcinoma and were operated 
by a single surgeon from 2004 to 2011. The postoperative follow-up time was 36 months. Results: the overall incidence of local recurrence 
was 2.4%. No patient in the lipofilling group had local recurrence during the study period. For systemic recurrence, the rates obtained 
were 3.7% (one patient) for the fat grafting group and 1.8% (three patients) for the conservative surgery group without reconstruction. 
Conclusion: there was no significant difference for local or systemic recurrence in the groups studied. Immediate autologous fat grafting 
appears to be a safe procedure.
Keywords: Breast Neoplasms. Neoplasm Recurrence, Local. Breast. Transplantation, Autologous. Reconstruction.
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incidence of cancer risk for patients undergoing fat graft 
reconstruction.
Using the same database, in 2013 Petit et 
al.9 exclusively evaluated patients with intraepithelial 
carcinoma, as they showed a higher risk of recurrence after 
fat grafting. There were 59 women with intraepithelial 
carcinoma undergoing fat grafting, and 118 women 
with no fat grafts as controls. They observed nine local 
recurrences, six in the fat grafting group and three in 
the control group (18% vs. 3%, p=0.02), confirming an 
increased risk. In the control group, however, there was a 
lower rate of recurrence compared with the rate generally 
found in patients with intraepithelial carcinomas, of 1% 
per year, suggesting that the different incidence found 
may not be statistically significant.
The objective of the present study was to 
compare rates of locoregional and systemic recurrence 
of breast cancer in patients submitted to autologous fat 
grafting simultaneously to conservative treatment with 
patients who underwent conservative treatment without 
reconstruction.
 METHODS
This is a historical cohort study of patients 
with invasive breast cancer submitted to conservative 
surgical treatment between January 2004 and December 
2011 in the Mastology Sector of the Clinics Hospital of 
Porto Alegre. We studied 194 patients, divided into two 
groups: group 1 or lipofilling group, with 27 patients 
undergoing breast conservative surgery with immediate 
autologous fat grafting in the years 2010 and 2011 
(year of beginning of the intervention) and group 2 
or breast conservative surgery (BCS) group, with 167 
patients undergoing conservative surgery without breast 
reconstruction, from 2004 to 2009. We perfumed the 
fat grafting by the Coleman technique and applied the 
fat grafting in different directions in the breast, including 
the tumor bed. In this technique, fat is liposuctioned from 
any part of the body, most commonly the abdomen, 
through a liposuction system under low pressure. This 
lipospired tissue is centrifuged and separated into three 
phases: blood, oil and purified adipose tissue. The oil 
and blood are discarded and the purified adipose tissue 
is injected into the retroglandular and subcutaneous 
region in small amounts and in different directions, 
including the tumor bed. In this way, the contact surface 
between the injected adipocytes and the receptor tissue 
is increased, increasing the probability of nutrition and 
incorporation of the new tissue. Bolus injection should 
not be performed because the excess fat in one place 
may not be absorbed, inducing the formation of areas of 
fatty necrosis. It is mandatory to graft a greater amount 
of adipose tissue than the defect itself because part of 
the transferred fat is reabsorbed. In experimental studies, 
up to 90% of transplanted adipose tissue may be lost, 
but clinical observation shows that the mean resorption 
is between 40% and 60%.
The patients studied had invasive breast 
carcinoma, clinical stages I and II, submitted to conservative 
surgery, with negative margins, and were followed up for 
36 months. The follow-up consisted of clinical evaluations 
every three months, with ultrasound and mammography 
every six months for evaluation of local recurrence, as 
well as chest X-ray, abdominal ultrasonography and 
bone scintigraphy for evaluation of systemic recurrence. 
We excluded patients who had already been treated for 
breast cancer. A single observer collected and reviewed 
the patients’ records.
The following variables were studied: age, 
tumor size, histological grade, staging, tumor type, 
hormone receptor expression, resection margins status, 
type of adjuvant treatment and presence or absence of 
local or systemic recurrence. We also evaluated serious 
postoperative complications that could delay adjuvant 
treatment and time to relapse diagnosis.
We entered the data into a SPSS (Statistical 
Package for Social Sciences, version 18.0) worksheet. For 
the statistical analysis, we compared the data using the 
chi-square test for categorical variables and the Student’s 
t or Mann-Whitney tests for continuous variables. We 
estimated recurrence curves using the Kaplan Meier 
method, and usedthe log rank test to compare the 
recurrence curves between groups. This difference has 
alpha =0.05 for a difference of 30%, power of 80%. The 
results were considered significant at p<0.05.
The present study was approved by the Ethics 
in Research Committee of the Clinics Hospital of Porto 
Alegre, under number 13-0401, and financed by the 
Mastology Sector of Clinics Hospital.
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carcinomas. The mean tumor size was 24.3±10.5mm in 
the lipofilling group and 20.6±12.0 in the BCS group. 
The mean time between surgery and the beginning of 
adjuvant treatment was one month in the lipofilling 
group and two months in the BCS group (Table 1). In the 
BCS group, 26 patients (15.6%) underwent neoadjuvant 
chemotherapy, compared with only one (3.7%) in the 
lipofilling group.
 RESULTS
The evaluation of the clinical and histological 
characteristics of each group did not reveal any statistically 
significant difference. The mean age was 53.6±10.9 
years in the lipofilling group and 56.4±12.0 years in 
the BCS group. All tumors were invasive carcinomas: 
173 invasive ductal carcinomas and 21 invasive lobular 
Table 1. Clinical and histological characteristics of the patients with invasive ductal carcinoma who underwent either conservative surgery with 
lipofilling or only conservative surgery.
BCS* + Lipofilling (n=27) BCS (n=167)
Age (mean in years) 53.6 ± 10.9 56,4 ± 12.0
Tumor size (mm) 24.3 ± 10.5 20.6 ± 12.0
Histological grading
I 7 (25.9) 38 (22.8)
II 9 (33.3) 85 (50.9)
III 11 (40,7) 44 (26.3)
Clinical staging (TNM)
I 7 (25.9) 78 (46.7)
II 20 (74.1) 89 (53.3)
Histology
IDC 24 (88.9) 149 (89.2)
ILC 3 (11.1) 18 (10.8)
Estrogen receptor
Present 22 (81.5) 128 (76.6)
Absent 5 (18.5) 39 (23.4)
Progesterone receptor
Present 22 (81.5) 116 (69.5)
Absent 5 (18.5) 51 (30.5)
HER2
Overexpressed 3 (11.1) 19 (11.4)
Not overexpressed 20 (74.1) 137 (82.0)
Undertermined 4 (14.8) 11 (6.6)
Neoadjuvant chemotherapy 1 (3.7) 26 (15.6)
Adjuvant chemotherapy 17 (63.0) 62 (37.1)
Adjuvant radiotherapy 27 (100) 163 (97.3)
Time to start of adjuvant therapy (months) 1 (1-2) 2 (1-4)
Categorical variables described as n (%); Symmetric quantitative variables described as means ± standard deviation; Asymmetric quantitative variables 
described as means (P25-P75); BCS- Breast Conservative Surgery; IDC- invasive ductal carcinoma; ILC- invasive lobular carcinoma.
We identified systemic recurrence in one 
patient (3.7%) in the lipofilling group and in seven (4.2%) 
in the BCS group. Comparison of the different types 
of recurrence did not reveal any statistically significant 
differences between the groups (Table 2).
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We diagnosed local recurrence in four patients 
(2.4%) in the BCS group and none in the lipofilling 
group. Of the recurrences identified, one presented 
as a nodule, one with microcalcifications and two with 
cutaneous presentation. We made the diagnoses of local 
recurrence by physical examination in three patients and 
by mammography, inone.
The evaluation of each group, according to the 
type of recurrence, did not show any differences in the 
incidence of local and systemic recurrence, and we did 
not find differences in disease-free survival (Figures 1, 2 
and 3).
Log rank test (p=0.902); BCS- breast conservative surgery.
Figure 1. Disease-free survival curve in lipofilling and conservative 
surgery groups up to time of recurrence.
Log rank test (p=0.521); BCS- breast conservative surgery.
Figure 2. Disease-free survival curve in lipofilling and conservative 
surgery groups up to time of systemic recurrence.
Test log rank (p=0.419) BCS- breast conservative surgery.
Figure 3. Disease-free survival curve in lipofilling and conservative 
surgery groups up to time of local recurrence.
Table 2. Recurrence in the lipofilling and breast conservative surgery groups.
BCS* + Lipofilling (n=27) BCS (n=167)
Overall recurrence 1 (3.7) 7 (4.2)
Local recurrence
Yes 7 (25.9) 38 (22.8)
No 9 (33.3) 85 (50.9)
Systemic recurrence
Yes 7 (25.9) 78 (46.7)
No 20 (74.1) 89 (53.3)
Categorical variables described as n (%); *BCS- Breast Conservative Surgery.
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 DISCUSSION
In 2014, Brenelli et al.10 published a prospective 
study of 59 patients who underwent 75 breast fat 
grafting procedures. All patients had undergone prior 
conservative treatment for oncological reasons and had 
a breast defect. They observed immediate complications 
in three cases, two cases of fat necrosis and one of 
cellulitis. Three cases of local recurrence were observed 
(4%) at 34 months of follow-up, 1.4% per year, an 
acceptable rate for conservative surgery. They diagnosed 
recurrences at different follow-up times, which may 
suggest that recurrence was not associated with the fat 
graft procedure.
Biazús et al.11 carried out a study at the Clinics 
Hospital of Porto Alegre, Brazil, in which the autologous 
fat graft procedure was performed simultaneously with 
conservative surgery. Twenty patients older than 21 
years, clinical stages I and II, underwent conservative 
surgery with immediate reconstruction with autologous 
fat according to the Coleman technique. Immediate 
injection of autologous adipose tissue facilitates repair 
of hard-to-resolve defects, which are often amplified by 
radiotherapy, especially in the inner and upper breast 
quadrants. These patients underwent adjuvant treatment 
following protocols of patients submitted to conservative 
surgery and are now under clinical and radiological follow-
up. Autologous fat grafting is a less invasive technique 
and results in a high level of patient satisfaction12-14.
In 2016, Moltó Garcia et al.15 published 
preliminary results of 37 immediate reconstructions of 
quadrantectomies with autologous fat grafting. They 
included both benign and malignant tumors. They avoided 
fat grafting in the same region of the quadrantectomy. 
All cases studied, with one year of follow up, showed 
excellent aesthetic results, even after radiotherapy. The 
complication rate was low and oncological safety was not 
compromised.
Autologous fat graftinghas been used for 
correction of body contouring or to correct soft tissue 
defects in different specialties for many years. In recent 
years, fat grafting has also been applied to restore 
breast contour and to stimulate neovascularization of 
irradiated mammary tissue that is chronically ischemic. 
Fat grafts supplement volume in unsatisfactory breast 
reconstruction results with breast implants, reduces 
capsular contracture, and improves the quality of breast 
reconstruction16-19. The technique was developed and 
applied by the Mastology Sector of the Clinics Hospital 
of Porto Alegre and has shown efficacy in patients with 
small breasts presenting with tumors in the inner and 
upper breast quadrants20.
In our group of patients submitted to 
immediate fat grafting and with 36 months of follow-up, 
we observed no local recurrence and there was only one 
case of systemic recurrence, comparable to the systemic 
recurrence rates described in the literature9,21. Some 
studies have shown a greater number of local recurrence 
in patients with intraductal carcinoma undergoing fat 
grafting in late reconstruction, but the numbers were 
not significant, since the control population showed a 
lower recurrence rate than expected (1% per year)5,7. 
We cannot compared that study to ours because the 
great majority of patients had undergone mastectomy, 
whereas the object of our study was only conservative 
procedures9.
We do not have studies about the risk or delay 
in the diagnosis of relapse in patients who were submitted 
to immediate fat grafting in the tumor bed of conservative 
surgery, because the first procedures with this technique 
were included in the study by Biazús et al.11, and these 
patients are still in follow-up. As all patients were treated 
following the institutional adjuvant protocols, we believe 
that there will be no difference between the two groups.
From a cosmetic point of view, Schultz et 
al.12 evaluated 44 patients who underwent fat grafting 
after conservative surgery or after breast reconstruction 
to correct deformities. Patients reported improvement 
in irregularities as well as in breast shape, in addition 
to increased volume and improved breast tissue 
consistency. Other authors have obtained the same 
aesthetic results11,13,14. This technique, as demonstrated 
by de Baclam et al.22, has been effective in the correction 
of deformities in the supero-medial quadrant of the 
reconstructed breast.
Largo et al.23, in a systematic review, reported 
that seven out of 12 studies aimed at gaining volume 
after fat grafting had good or excellent results. However, 
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only Zocchi and Zuliani24 used a standard protocol 
for satisfaction assessment (excellent, good, fair and 
insufficient). The other studies did not specify how they 
assessed patient satisfaction.
Regarding imaging tests, we verified that fat 
grafting does not cause additional difficulties in the 
radiological evaluation of suspicious alterations25-28. 
Radiologists can distinguish, with a high level of 
confidence, calcifications due to fat necrosis from those 
related to breast cancer29. Claro et al.8 reported that, 
in 17 studies with 2,560 patients, the rate of abnormal 
radiographic changes after fat grafting was 13% after 
a 12-month follow-up, data similar to changes that are 
visualized after any breast surgical procedure. The most 
common abnormal radiological findings were cysts 
(74.6%) and microcalcifications (13.4%). In addition, 
there was no statistically significant difference in breast 
tissue density and in Breast Imaging Reporting and Data 
System (BIRADS) classification before and after breast 
fat grafting in 20 patients with no history of breast 
disease23,25.
In any case, failure to diagnose a new cancer 
is a problem that can occur after any breast surgery. 
Therefore, the same surveillance used to monitor patients 
after conservative breast treatment should be used after 
fat graft reconstruction29.
Despite the limitation of the study by the small 
number of patients in the lipofilling group, the use of fat 
grafting in conservative surgery seems safe. Induction of a 
new tumor or accelerated growth of a pre-existing one by 
fat grafting has also not been confirmed in other studies, 
as well as there is no scientific evidence of breast cancer or 
local recurrence after fat grafting in conservative surgery. 
The technique is promising in patients with invasive 
cancer. It is simple and provides restoration of shape and 
volume, with natural texture. This approach may replace 
more complex procedures, such as intervention in the 
other breast to obtain symmetry, and is a good alternative 
in small and medium volume breasts. With the success of 
the technique, women with larger tumors and with an 
unfavorable tumor/breast volume ratio for conservative 
surgery tend to benefit from this type of reconstruction.
Objetivo: avaliar recorrência local e sistêmica do câncer de mama em pacientes submetidas ao enxerto autólogo de gordura na 
reconstrução imediata após cirurgia conservadora para o câncer de mama. Métodos: estudo de coorte histórica em que foram 
comparadas 167 pacientes submetidas à cirurgia conservadora sem reconstrução com 27 pacientes submetidas ao tratamento 
conservador com reconstrução imediata do enxerto, seguindo técnica de Coleman. Todas as pacientes eram portadoras de carcinoma 
invasor e foram operadas por um único cirurgião, no período de 2004 a 2011. O tempo de acompanhamento pós-operatório foi 36 
meses. Resultados: a incidência global de recidiva local foi 2,4%. Nenhuma paciente do grupo de lipoenxertia apresentou recorrência 
local durante o período do estudo.  Para recorrência sistêmica, as taxas obtidas foram de 3,7% (uma paciente) para o grupo lipoenxertia 
e 1,8% (três pacientes) para grupo da cirurgia conservadora sem reconstrução. Conclusão: não houve diferença significativa para 
recorrência local ou sistêmica nos grupos estudados. O enxerto autólogo imediato de gordura parece ser um procedimento seguro.
Descritores: Reconstrução. Mama. Neoplasias da Mama. Recidiva Local de Neoplasia. Transplante Autólogo.
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Erratum
In March/April 2017, the Journal of the Brazilian College of Surgeons [Rev Col Bras Cir. 2017;44(2):179-
86] published the original article titled “Immediate 
reconstruction with autologous fat grafting: influence 
in breast cancerregional recurrence.” (http://dx.doi.
org/10.1590/0100-69912017002012), by Camile Cesa 
Stumpf; Jorge Villanova Biazus; Fernando Schuh Ângela 
Erguy Zucatto; Rodrigo Cericatto; José Antônio Crespo 
Cavalheiro; Andrea Pires Souto Damin; Márcia Portela 
Melo. The following errors were identified:
 Title:
Reads:
“…influence in breast cancerregional recurrence”;
Should read:
“…influence in loco regional recurrence in breast cancer.
 Tables:
Reads:
Table 1. Clinical and histological characteristics of the patients with invasive ductal carcinoma who underwent either conservative surgery with 
lipofilling or only conservative surgery.
BCS* + Lipofilling (n=27) BCS (n=167)
Age (mean in years) 53.6 ± 10.9 56.4 ± 12.0
Tumor size (mm) 24.3 ± 10.5 20.6 ± 12.0
Histological grading
I 7 (25.9) 38 (22.8)
II 9 (33.3) 85 (50.9)
III 11 (40.7) 44 (26.3)
Clinical staging (TNM)
I 7 (25.9) 78 (46.7)
II 20 (74.1) 89 (53.3)
Histology
IDC 24 (88.9) 149 (89.2)
ILC 3 (11.1) 18 (10.8)
Estrogen receptor
Present 22 (81.5) 128 (76.6)
Absent 5 (18.5) 39 (23.4)
Progesterone receptor
Present 22 (81.5) 116 (69.5)
Absent 5 (18.5) 51 (30.5)
HER2
Overexpressed 3 (11.1) 19 (11.4)
Not overexpressed 20 (74.1) 137 (82.0)
Undertermined 4 (14.8) 11 (6.6)
Neoadjuvant chemotherapy 1 (3.7) 26 (15.6)
Adjuvant chemotherapy 17 (63.0) 62 (37.1)
Adjuvant radiotherapy 27 (100) 163 (97.3)
Time to start of adjuvant therapy (months) 1 (1-2) 2 (1-4)
Categorical variables described as n (%); Symmetric quantitative variables described as means ± standard deviation; Asymmetric quantitative variables 
described as means (P25-P75); BCS- Breast Conservative Surgery; IDC- invasive ductal carcinoma; ILC- invasive lobular carcinoma.
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Should read:
Table 1. Clinical and histological characteristics of the patients with invasive ductal carcinoma who underwent either conservative surgery with 
lipofilling or only conservative surgery.
BCS* + Lipofilling (n=27) BCS (n=167) p
Age (mean in years) 53.6 ± 10.9 56.4 ± 12.0 0.268
Tumor size (mm) 24.3 ± 10.5 20.6 ± 12.0 0.134
Histological grading 0.194
I 7 (25.9) 38 (22.8)
II 9 (33.3) 85 (50.9)
III 11 (40.7) 44 (26.3)
Clinical staging (TNM) 0.070
I 7 (25.9) 78 (46.7)
II 20 (74.1) 89 (53.3)
Histology 1.000
IDC** 24 (88.9) 149 (89.2)
ILC*** 3 (11.1) 18 (10.8)
Estrogen receptor 0.757
Present 22 (81.5) 128 (76.6)
Absent 5 (18.5) 39 (23.4)
Progesterone receptor 0.294
Present 22 (81.5) 116 (69.5)
Absent 5 (18.5) 51 (30.5)
HER2 0.330
Overexpressed 3 (11.1) 19 (11.4)
Not overexpressed 20 (74.1) 137 (82.0)
Undertermined 4 (14.8) 11 (6.6)
Neoadjuvant chemotherapy 1 (3.7) 26 (15.6) 0.135
Adjuvant chemotherapy 17 (63.0) 62 (37.1) 0.020
Adjuvant radiotherapy 27 (100) 163 (97.3) 1.000
Time to start of adjuvant therapy (months) 1 (1-2) 2 (1-4) 0.041
Categorical variables described as n (%); Symmetric quantitative variables described as means ± standard deviation; Asymmetric quantitative variables 
described as means (P25-P75); *BCS- Breast Conservative Surgery; **IDC- invasive ductal carcinoma; ***ILC- invasive lobular carcinoma.
Reads:
Table 2. Recurrence in the lipofilling and breast conservative surgery groups.
BCS* + Lipofilling (n=27) BCS (n=167)
Overall recurrence 1 (3.7) 7 (4.2)
Local recurrence
Yes 7 (25.9) 38 (22.8)
No 9 (33.3) 85 (50.9)
Systemic recurrence
Yes 7 (25.9) 78 (46.7)
No 20 (74.1) 89 (53.3)
Categorical variables described as n (%); *BCS- Breast Conservative Surgery.
Should read:
Table 2. Recurrence in the lipofilling and breast conservative surgery groups.
BCS* + Lipofilling (n=27) BCS (n=167) p
Overall recurrence 1 (3.7) 7 (4.2) 1.000
Local recurrence 1.000
Yes 0 (0.0) 4 (2.4)
No 27 (100) 163 (95.8)
Systemic recurrence 0.454
Yes 1 (3.7) 3 (1.8)
No 26 (96.3) 164 (98.2)
Categorical variables described as n (%); *BCS- Breast Conservative Surgery.
